Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan
- PMID: 30819710
- PMCID: PMC6398622
- DOI: 10.1136/bmjopen-2018-025455
Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan
Abstract
Objective: To understand the efficacy of aspirin use for preventing ischaemic stroke after central retinal artery occlusion (CRAO).
Design: The retrospective cohort study was conducted using the National Health Insurance Research Database from 1998 to 2013.
Setting: A population-based study.
Participants: A total of 9437 participants with newly diagnosed CRAO were identified. Participants who had a previous stroke and/or retinal vascular occlusion, were aged <20 years and used aspirin 3 months before the event were excluded. There were 3778 eligible participants matched by propensity score, and they were divided into aspirin (n=434) and aspirin-naive (n=1736) groups after the matching.
Methods: Cox proportional hazard models and cumulative survival curves were used to assess ischaemic stroke in the study groups, along with log-rank tests to compare group differences.
Main outcome measures: Incidence of ischaemic stroke in the aspirin and aspirin-naive groups 1 year after CRAO.
Results: Of the 3778 patients with newly diagnosed CRAO, 151 (4%) had a subsequent ischaemic stroke within 1 year. The risk was especially high during the first week of the CRAO. No difference between the aspirin and aspirin-naive groups was found in risk of ischaemic stroke, haemorrhagic stroke, gastrointestinal bleeding, major bleeding, acute coronary syndrome, retinal vein occlusion, new-onset glaucoma, undergoing panretinal photocoagulation or all-cause mortality. Risk factors for ischaemic stroke within 1 year of CRAO included male gender (p=0.031; HR=1.46) and age (p=0.032; HR=1.14).
Conclusions: Aspirin use after a CRAO showed no benefit on attenuating the risk of ischaemic stroke. The risk of ischaemic stroke was increased after CRAO especially during the first week. Male gender and age were risk factors for ischaemic stroke after CRAO.
Keywords: aspirin; central retinalarterial occlusion; ischemic stroke prevention; riskfactor.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Risk of Mortality and of Atherosclerotic Events Among Patients Who Underwent Hemodialysis and Subsequently Developed Retinal Vascular Occlusion: A Taiwanese Retrospective Cohort Study.JAMA Ophthalmol. 2016 Feb;134(2):196-203. doi: 10.1001/jamaophthalmol.2015.5052. JAMA Ophthalmol. 2016. PMID: 26720586
-
Risk and Risk Periods for Stroke and Acute Myocardial Infarction in Patients with Central Retinal Artery Occlusion.Ophthalmology. 2015 Nov;122(11):2336-2343.e2. doi: 10.1016/j.ophtha.2015.07.018. Epub 2015 Aug 19. Ophthalmology. 2015. PMID: 26298716
-
[Systemic lysis therapy in retinal vascular occlusions].Ophthalmologe. 1998 Aug;95(8):568-75. doi: 10.1007/s003470050318. Ophthalmologe. 1998. PMID: 9782735 Review. German.
-
Intravenous Fibrinolytic Therapy in Central Retinal Artery Occlusion: A Patient-Level Meta-analysis.JAMA Neurol. 2015 Oct;72(10):1148-54. doi: 10.1001/jamaneurol.2015.1578. JAMA Neurol. 2015. PMID: 26258861
-
Prevalent misconceptions about acute retinal vascular occlusive disorders.Prog Retin Eye Res. 2005 Jul;24(4):493-519. doi: 10.1016/j.preteyeres.2004.12.001. Prog Retin Eye Res. 2005. PMID: 15845346 Review.
Cited by
-
Antithrombotic use in retinal artery occlusion: A narrative review.Kaohsiung J Med Sci. 2025 Apr;41(4):e12938. doi: 10.1002/kjm2.12938. Epub 2025 Jan 16. Kaohsiung J Med Sci. 2025. PMID: 39817651 Free PMC article. Review.
-
The Impact of the Initial Admission Department on the Management and Prognosis of Retinal Artery Occlusion.Curr Neurovasc Res. 2022;19(5):440-448. doi: 10.2174/1567202620666221027091249. Curr Neurovasc Res. 2022. PMID: 36305143
-
[Nonaretritic central retinal artery occlusion as marker for the generalized vascular risk].Ophthalmologe. 2021 Nov;118(11):1093-1098. doi: 10.1007/s00347-021-01466-6. Epub 2021 Aug 4. Ophthalmologe. 2021. PMID: 34350493 Review. German.
-
Statin Treatment on Cardiovascular Risk After Retinal Artery Occlusion: A Historical Cohort Study.J Epidemiol Glob Health. 2023 Dec;13(4):685-695. doi: 10.1007/s44197-023-00143-y. Epub 2023 Aug 12. J Epidemiol Glob Health. 2023. PMID: 37572209 Free PMC article.
-
Risk of Stroke, Myocardial Infarction, and Death Among Patients With Retinal Artery Occlusion and the Effect of Antithrombotic Treatment.Transl Vis Sci Technol. 2021 Sep 1;10(11):2. doi: 10.1167/tvst.10.11.2. Transl Vis Sci Technol. 2021. PMID: 34468694 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical